New Jersey's shrinking pharmaceutical and telecom industries have hurt the state's ability to attract venture capital, which peaked in 2004 and has fallen steadily since then.
Venture capital investment in the state continued its nearly decade-long downward slide in 2012, totaling $429.3 million, according to MoneyTree Report by PricewaterhouseCoopers LLP and the National Venture Capital Association, based on data from Thomson Reuters.
To read the original article: N.J. continues decline in drawing venture capital - NorthJersey.com
